Interaction of 6-Thioguanine with Aluminum Metal–Organic Framework Assisted by Mechano-Chemistry, In Vitro Delayed Drug Release, and Time-Dependent Toxicity to Leukemia Cells
Open Access
- 29 September 2024
- journal article
- research article
- Published by MDPI AG in Nanomaterials
- Vol. 14 (19) , 1571
Abstract
6-thioguanine (6-TG) is an antimetabolite drug of purine structure, approved by the FDA for the treatment of acute myeloid lesukemia, and it is of interest in treating other diseases. The interaction of drugs with matrices is of interest to achieving a delayed, sustained, and local release. The interaction of 6-TG with an aluminum metal–organic framework (Al-MOF) DUT-4 is studied using a novel experimental approach, namely, mechano-chemistry by liquid-assisted grinding (LAG). The bonding of 6-TG to the DUT-4 matrix in the composite (6-TG)(DUT-4) was studied using ATR-FTIR spectroscopy and XRD. This interaction involves amino groups and C and N atoms of the heterocyclic ring of 6-TG, as well as the carboxylate COO− and (Al)O-H groups of the matrix, indicating the formation of the complex. Next, an in vitro delayed release of 6-TG was studied from composite powder versus pure 6-TG in phosphate buffered saline (PBS) at 37 °C. Herein, an automated drug dissolution apparatus with an autosampler was utilized, and the molar concentration of the released 6-TG was determined using an HPLC–UV analysis. Pure 6-TG shows a quick (<300 min) dissolution, while the composite gives the dissolution of non-bonded 6-TG, followed by a significantly (factor 6) slower release of the bonded drug. Each step of the release follows the kinetic pseudo-first-order rate law with distinct rate constants. Then, a pharmaceutical shaped body was prepared from the composite, and it yields a significantly delayed release of 6-TG for up to 10 days; a sustained release is observed with the 6-TG concentration being within the therapeutically relevant window. Finally, the composite shows a time-dependent (up to 9 days) stronger inhibition of leukemia MV-4-11 cell colonies than 6-TG.Keywords
Funding Information
- National Institute of General Medical Sciences (UL1GM118973)
This publication has 42 references indexed in Scilit:
- Advances in Thiopurine Drug Delivery: The Current State-of-the-ArtEuropean Journal of Drug Metabolism and Pharmacokinetics, 2021
- Quaternary polymethacrylate−magnesium aluminum silicate film formers: Stability studies for tablet coatingsJournal of Drug Delivery Science and Technology, 2021
- A comparative study of the physical and chemical properties of pelletized HKUST-1, ZIF-8, ZIF-67 and UiO-66 powdersHeliyon, 2020
- Aluminum metal–organic frameworks for sorption in solution: A reviewCoordination Chemistry Reviews, 2018
- Construction of 6-thioguanine and 6-mercaptopurine carriers based on βcyclodextrins and gold nanoparticlesCarbohydrate Polymers, 2017
- On the comparison of pseudo-first order and pseudo-second order rate laws in the modeling of adsorption kineticsChemical Engineering Journal, 2016
- Induction of cancer cell death by apoptosis and slow release of 5-fluoracil from metal-organic frameworks Cu-BTCBiomedicine & Pharmacotherapy, 2013
- Local drug delivery strategies for cancer treatment: Gels, nanoparticles, polymeric films, rods, and wafersJournal of Controlled Release, 2012
- Characterization and Quantification of Amorphous Material in Milled and Spray-Dried Salbutamol Sulfate: A Comparison of Thermal, Spectroscopic, and Water Vapor Sorption ApproachesJournal of Pharmaceutical Sciences, 2011
- The cytotoxicity of thioguanine vs mercaptopurine in acute lymphoblastic leukemiaLeukemia Research, 1994